114.98
Overview
News
Price History
Option Chain
Financials
Why CLX Down?
Discussions
Forecast
Stock Split
Dividend History
Clorox Co stock is traded at $114.98, with a volume of 2.72M.
It is up +1.49% in the last 24 hours and up +14.01% over the past month.
Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.
See More
Previous Close:
$113.29
Open:
$111.92
24h Volume:
2.72M
Relative Volume:
1.16
Market Cap:
$14.03B
Revenue:
$7.10B
Net Income/Loss:
$824.00M
P/E Ratio:
17.62
EPS:
6.5244
Net Cash Flow:
$761.00M
1W Performance:
+1.58%
1M Performance:
+14.01%
6M Performance:
-6.60%
1Y Performance:
-28.04%
Clorox Co Stock (CLX) Company Profile
Name
Clorox Co
Sector
Industry
Phone
(510) 271-7000
Address
THE CLOROX COMPANY, OAKLAND, CA
Compare CLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CLX
Clorox Co
|
114.98 | 13.82B | 7.10B | 824.00M | 761.00M | 6.5244 |
|
PG
Procter Gamble Co
|
155.32 | 356.01B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
69.15 | 149.97B | 64.99B | 6.71B | 6.53B | 2.74 |
|
CL
Colgate Palmolive Co
|
93.15 | 74.07B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
EL
Estee Lauder Cos Inc
|
116.27 | 42.80B | 14.42B | -930.00M | 1.05B | -2.5832 |
|
KVUE
Kenvue Inc
|
17.59 | 33.30B | 15.01B | 1.43B | 1.63B | 0.744 |
Clorox Co Stock (CLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-25 | Reiterated | Barclays | Underweight |
| Jan-07-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Nov-06-24 | Upgrade | TD Cowen | Sell → Hold |
| Oct-01-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-23-24 | Initiated | TD Cowen | Sell |
| Jun-24-24 | Initiated | Exane BNP Paribas | Underperform |
| Apr-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Mar-26-24 | Upgrade | Jefferies | Underperform → Hold |
| Mar-01-24 | Resumed | Goldman | Sell |
| Feb-05-24 | Downgrade | DA Davidson | Buy → Neutral |
| Dec-15-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-22-23 | Upgrade | JP Morgan | Underweight → Neutral |
| Nov-13-23 | Initiated | Jefferies | Underperform |
| Nov-06-23 | Upgrade | UBS | Sell → Neutral |
| Nov-02-23 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Oct-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-02-23 | Upgrade | DA Davidson | Neutral → Buy |
| Sep-22-23 | Initiated | HSBC Securities | Hold |
| Aug-03-23 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Feb-17-23 | Initiated | Citigroup | Neutral |
| Oct-18-22 | Initiated | Evercore ISI | Underperform |
| Oct-17-22 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-14-22 | Resumed | BofA Securities | Underperform |
| Jul-13-22 | Initiated | Raymond James | Outperform |
| Feb-04-22 | Downgrade | Atlantic Equities | Neutral → Underweight |
| Feb-04-22 | Reiterated | Deutsche Bank | Hold |
| Feb-04-22 | Reiterated | JP Morgan | Underweight |
| Feb-04-22 | Reiterated | Morgan Stanley | Underweight |
| Feb-04-22 | Reiterated | UBS | Sell |
| Feb-04-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | Bernstein | Mkt Perform → Underperform |
| Jan-26-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-02-21 | Reiterated | DA Davidson | Neutral |
| Nov-02-21 | Reiterated | Deutsche Bank | Hold |
| Nov-02-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-02-21 | Reiterated | Wells Fargo | Underweight |
| Sep-03-21 | Downgrade | Argus | Buy → Hold |
| Aug-04-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Aug-04-21 | Reiterated | Citigroup | Buy |
| Aug-04-21 | Reiterated | Credit Suisse | Neutral |
| Aug-04-21 | Reiterated | Deutsche Bank | Hold |
| Aug-04-21 | Reiterated | Morgan Stanley | Underweight |
| Aug-04-21 | Reiterated | RBC Capital Mkts | Sector Perform |
| Aug-04-21 | Reiterated | UBS | Sell |
| Aug-04-21 | Reiterated | Wells Fargo | Underweight |
| Jun-24-21 | Initiated | UBS | Sell |
| May-03-21 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-18-21 | Downgrade | DA Davidson | Buy → Neutral |
| Feb-19-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-20-21 | Initiated | Bernstein | Mkt Perform |
| Dec-14-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-08-20 | Initiated | Wells Fargo | Overweight |
| Oct-16-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-20 | Initiated | DA Davidson | Buy |
| Mar-19-20 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-16-20 | Upgrade | JP Morgan | Underweight → Overweight |
| Mar-09-20 | Upgrade | Argus | Hold → Buy |
| Oct-03-19 | Reiterated | BofA/Merrill | Neutral |
| Sep-23-19 | Downgrade | Barclays | Equal Weight → Underweight |
| May-20-19 | Downgrade | Argus | Buy → Hold |
| May-02-19 | Reiterated | BofA/Merrill | Neutral |
| May-02-19 | Upgrade | Deutsche Bank | Sell → Hold |
| Apr-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-07-19 | Initiated | Credit Suisse | Outperform |
| Dec-06-18 | Reiterated | BofA/Merrill | Neutral |
| Sep-25-18 | Upgrade | Argus | Hold → Buy |
| Jul-18-18 | Downgrade | Goldman | Neutral → Sell |
| Apr-19-18 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-08-18 | Downgrade | Argus | Buy → Hold |
| Jan-04-18 | Upgrade | BofA/Merrill | Underperform → Neutral |
View All
Clorox Co Stock (CLX) Latest News
Clorox Co (CLX) Q2 2026 Earnings Call Highlights: Navigating Cha - GuruFocus
Decoding Clorox Co (CLX): A Strategic SWOT Insight - GuruFocus
The Clorox Company (CLX): A bull case theory - MSN
The Clorox Company (CLX): A Bull Case Theory - Yahoo Finance UK
Clorox (CLX) misses Q2 earnings estimates - MSN
Clorox (CLX) Q2 Earnings Miss Expectations, Revenue Surpasses Es - GuruFocus
Earnings call transcript: Clorox Q2 2026 sees mixed results and stock dip - Investing.com
Clorox: Overview of Fiscal Second Quarter Earnings - Bitget
CLOROX CO /DE/ SEC 10-Q Report - TradingView
Clorox Earnings Review: Q2 Summary - Benzinga
Clorox (NYSE:CLX) Posts Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Transforming our operations: Clorox completes ERP rollout across US and Canada - The Clorox Company
Clorox shares slip 2% as Q2 earnings miss overshadows revenue beat, driven by higher costs - Investing.com Nigeria
Chair and CEO Linda Rendle on Q2 earnings and outlook for FY26 - The Clorox Company
Clorox’s (NYSE:CLX) Q4 CY2025: Beats On Revenue - The Globe and Mail
Aug Big Picture: Is The Clorox Company stock a smart retirement pickJuly 2025 Intraday Action & Fast Moving Stock Trade Plans - baoquankhu1.vn
Clorox Settles Male Worker's Gender Bias Suit On Eve Of Trial - Law360
Clorox (CLX) Sees Normal Pre-Earnings Options Activity with Calls Outpacing Puts - GuruFocus
Clorox (CLX) Leads Consumer Staples Stocks with Strong YTD Perfo - GuruFocus
I Tried the New Clorox Sink Mat With a Rinse Rack—Here’s Why It Works So Well - Dengarden
Clorox earnings on deck as GOJO deal reshapes growth outlook - Investing.com
Clorox earnings on deck as GOJO deal reshapes growth outlook By Investing.com - Investing.com UK
Mediolanum International Funds Ltd Has $3.57 Million Position in The Clorox Company $CLX - MarketBeat
Federated Hermes Inc. Reduces Holdings in The Clorox Company $CLX - MarketBeat
Clorox fined $14.15M for delayed warning about Pine-Sol bacteria - MSN
Earnings Outlook For Clorox - Benzinga
Bank of New York Mellon Corp Grows Position in The Clorox Company $CLX - MarketBeat
Yacktman Asset Management LP Raises Holdings in The Clorox Company $CLX - MarketBeat
Earnings To Watch: Clorox (CLX) Reports Q4 Results Tomorrow - Finviz
Assessing Clorox (CLX) Valuation After Recent Share Price Rebound And Longer Term Weakness - simplywall.st
Clorox Weighs GOJO Expansion Against Safety Penalty And Compliance Risks - Yahoo Finance UK
Clorox Balances Pine Sol Penalty And GOJO Deal With Valuation Discount - simplywall.st
The Clorox Company $CLX Shares Sold by Teacher Retirement System of Texas - MarketBeat
Can Clorox Deliver a Q2 Earnings Beat Despite Cost Headwinds? - The Globe and Mail
Y Intercept Hong Kong Ltd Has $2.30 Million Holdings in The Clorox Company $CLX - MarketBeat
The Clorox Company $CLX Shares Purchased by Vanguard Personalized Indexing Management LLC - MarketBeat
Is Clorox (CLX) Offering Value After A Mixed Share Price Performance? - simplywall.st
Clorox Fined $14.15M For Delayed Warning About Pine-Sol Bacteria - dailyvoice.com
Procter & Gamble vs. Clorox: Which Household Name Is Worth Watching? - The Globe and Mail
Is Clorox (CLX) Pricing Look Attractive After Recent Share Price Rebound - Yahoo Finance
SETTLEMENT AGREEMENTS—HOUSEHOLD PRODUCTS: CPSC provisionally accepts $14.15 million settlement with Clorox over delayed reporting of bacterial contamination in Pine-Sol products - VitalLaw.com
Deutsche Bank Adjusts Clorox (CLX) Valuation Following GOJO Purchase - Insider Monkey
Clorox fined $14.15M for failing to report product contamination to consumer watchdog - MSN
Clorox (CLX) Faces $14.15M Penalty Over Pine-Sol Product Safety Violation - GuruFocus
Clorox agrees to pay $14.15M civil penalty over Pine-Sol bacterial hazard - WFTV
CPSC Fines Clorox $14.15 Million for Pine-Sol Safety Issues - Happi | Household And Personal Products Industry
Clorox fined $14.15M for failing to report product contamination to consumer watchdog (CLX:NYSE) - Seeking Alpha
Clorox (CLX) Settles with CPSC for $14.15 Million Over Product R - GuruFocus
Clorox Agrees to Pay $14.15 Million Civil Penalty for Failure to Immediately Report Bacterial Hazard with Pine-Sol Scented Multi-Surface Cleaning Products - CPSC.gov
Cooley, Jones Day act on Clorox’s $2.25bn acquisition of Purell-maker - Managing Intellectual Property
Analysts Estimate Clorox (CLX) to Report a Decline in Earnings: What to Look Out for - Finviz
Clorox Co Stock (CLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):